The Experts in Animal Health

***********************************
Brakke Consulting’s
Animal Health News & Notes for January 31, 2020
Copyright © Brakke Consulting

Editor: Lynn Fondon DVM MBA
************************************

IN THE NEWS:

Brakke Consulting News
2020 Industry Overview at WVC

Earnings News
Alivira Animal Health
Vetoquinol

Other News
Angus Genetics, Inc.
Automazioni
Cardinal Laboratories
Imbed Biosciences
Kane Biotech
MedTech MedCare
Memphis Meats
Merck
Neogen
Norbrook
Patterson Veterinary
Phibro
Replenish
Vetology
Whitebridge Pet Brands
Zomedica

***********************************
Announcing the 2020 Brakke Industry Overview

Information to keep you ahead of the packPresented at WVC: February 18, 2020, 2-4 pm, Four Seasons Hotel, Acacia Ballroom

What do industry consolidation, CBD and African Swine Fever have in common?  They are all important topics covered in Brakke Consulting’s annual Industry Overview presented at VMX and WVC in early 2020.

2019 was an especially newsy year, and many events have long-range implications for the animal health industry.  Key topics and presenters include:

  • Industry performance and a special analysis of the public companies in animal health (Dr. Bob Jones and Randy Freides)
  • Vet practice consolidation, CBD, monoclonal antibodies and other new companion animal technologies (John Volk)
  • Disruptive technologies and the changing landscape of the diagnostics industry (Dr. Mike McGinley)
  • African Swine fever, plant-based meat and milk products and their impact on protein and animal health product demand (Dr. Cary Christensen)

This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy and finance managers.

To register, sign up today by clicking here, or email Amanda McDavid amcdavid@brakkeconsulting.com or call her at 336-396-3916.  Pre-registration cost for WVC is $400; there are discounts for multiple attendees from the same company.  We look forward to seeing you there!

www.BrakkeConsulting.com

************************************
COMPANY EARNINGS RELEASES

  • The Vetoquinol Group reported results for the full year 2019. Sales were EUR 396 million ($443 million), an increase of 7.6% as reported (+6.1% at constant exchange rates). All Vetoquinol strategic territories posted growth in 2019, with the Americas up 11%, Europe up 4% and Asia Pacific up 2% at constant exchange rates. Growth in the Americas was boosted by Clarion sales in Brazil from April 2019. (Yahoo finance)
  • SeQuent Scientific Limited, parent company of Alivira Animal Health, announced financial results for its third fiscal quarter ended December 31, 2019. Revenues were INR 3,164 million ($44 million), an increase of 17% year-over-year. (company press release)

************************************
COMPANY NEWS RELEASES

  • Merck Animal Health, in partnership with Automazioni, announced the launch of Innoject Pro, a new subcutaneous chick vaccination technology. Innoject Pro features an eye and nasal drop vaccination system in combination with subcutaneous application. Innoject Pro can be used in combination with MSD’s Innovax range of vaccines. (Animal Pharm)
  • Phibro Animal Health Corporation announced the launch of two new products: Quantic Pulse, a nutritional specialty product to help swine producers reduce the moisture in swine feed; and Dryd, a new drying agent to help piglets stay dry and start strong. Dryd can also be used as a litter desiccant for ruminants and poultry. (ThePigSite.com)
  • Norbrook announced the launch of Selarid (selamectin) generic spot-on parasiticide. Selarid is indicated to fight fleas, heartworm disease and ear mites in dogs and cats. It also controls American dog tick infestations and treats and controls sarcoptic mange in dogs; and treats and controls roundworms and intestinal hookworms in cats. (Todays Veterinary Business)
  • Neogen Corporation announced that it and Angus Genetics, Inc. (AGI) have launched updated content to Angus GSSM, the first genomic profiler designed specifically for Angus cattle. This additional content includes 25,000 SNPs (single nucleotide polymorphisms) which are particularly relevant for traits of interest relating to calving ease, birth weight, marbling, and heifer pregnancy. (company press release)
  • Patterson Veterinary announced a partnership with Vetology to offer Vetology’s AI Radiograph Analysis Software to Patterson customers. The artificial intelligence software allows veterinarians to obtain remote radiograph read reports in approximately three minutes. (Vet Advantage)
  • Zomedica announced it is shifting tactics to concentrate on its veterinary diagnostics, which should go on sale before the end of the year. The firm is seeking partners to continue the development and commercialization of its therapeutic pipeline, as well as its canine cancer reference laboratory liquid biopsy platform. (Animal Pharm)
  • Replenish, an all-natural powdered water supplement for active dogs, was developed and launched by Rachel Walsh, DVM. Replenish entices dogs to drink more water in order to restore hydration and replace core nutrients lost during physical exertion; and contains carbohydrates, vitamins, and antioxidants to refuel lost cellular energy and combat oxidative damage. The product is available through Amazon or through the website at www.replenishdog.com. (company announcement)
  • Imbed Biosciences recently launched a new veterinary division to provide its MicroLyte Ag VET wound dressing product. MicroLyte Ag VET helps wounds heal by applying a specially designed layer of antimicrobial silver that doesn’t inhibit healing. New cells can form on top of the MicroLyte Ag VET, which completely absorbs into the body. (company press release)
  • Whitebridge Pet Brands announced the acquisition of Cardinal Laboratories, Inc. (Cardinal Pet Care). Financial terms were not disclosed. (Petfood Industry)
  • MedTech/MedCare (MTMC) announced it is expanding into the veterinary industry after 35 years of providing manufacturer sales representatives to human health care companies. MTMC’s new animal health division will focus on sales representation, outbound telesales, national accounts representation, distribution representation, biomedical services and consulting services. (company press release)
  • Memphis Meats announced it has finalized a $161 million series B funding round – the largest ever in the cell-based meat industry to date. The company is developing methods to produce meat directly from animal cells, without the need to breed or slaughter animals. It released the world’s first cell-based meatball in 2016 and the world’s first cell-based poultry in 2017 as proof-of-concept prototype products. (Animal Pharm)
  • CANADA Kane Biotech announce that it has retained Independent Trading Group, Inc. (“ITG”), an independent, privately held broker-dealer based in Toronto, Ontario, to provide market-making services to the Company. ITG will trade shares of Kane Biotech on the TSX Venture Exchange. (company press release)

***********************************
ANIMAL HEALTH STOCK PRICE TRACKER

***********************************
ANIMAL HEALTH NEWS

  • US – VET SCHOOLS A 30-second commercial featuring UW-Madison’s School of Veterinary Medicine will air Sunday during the Super Bowl. WeatherTech, an automotive accessories, home and pet care products manufacturer, is footing the $6 million bill and also supplying the star talent — company founder and CEO David MacNeil’s dog, Scout.  Scout was diagnosed with a tumor on his heart, which was treated successfully by UW’s oncologists. Some of the faculty and staff will appear alongside the 7-year-old golden retriever in the commercial that follows Scout’s journey to recovery. Watch the ad here: (Wisconsin State Journal)
  • EU – ASF According to the latest update from the European Food Safety Authority (EFSA), African swine fever (ASF) is still spreading slowly throughout Europe in a southwesterly direction. Between November 2018 and October 2019, Czechia became officially ASF-free but  the disease was confirmed in Slovakia. There continues to be nine affected countries in the EU. (Animal Pharm)
  • US – ASF Researchers from the USDA’s Plum Island Animal Disease Center have developed an experimental African swine fever (ASF) vaccine that has shown early signs of viability. The experimental vaccine works by deleting a gene called I177L, and the research suggested both low and high doses of the vaccine were 100% effective against the virus when the pigs were challenged 28 days post-inoculation. The research was published in the Journal of Virology. (Animal Pharm)
  • EU The European Medicines Agency (EMA) has updated its categorization of antibiotics used in animals to promote responsible use. The classification now features four categories: Category A (‘Avoid’); Category B (‘Restrict’); Category C (‘Caution’); and Category D (‘Prudence’). The new advice, including the scientific rationale behind the categorization, can be found here. (Animal Pharm)
  • US – FDA The FDA has expanded its Fiscal Year 2019 funding opportunity and is announcing a new FY 2020 funding opportunity and Request for Applications (RFA) for studies that can generate data to help establish more targeted durations of use for certain medically important antimicrobial drugs approved for use in the feed of food-producing animals. For more information, click here.

************************************
BRAKKE CONSULTING VIEWPOINT

More money for a lab-based meat company, traditional animal health companies look to adjacencies for growth, and a new topical generic parasiticides hits the market.  All these news items in this week’s News & Notes are topics that will be covered in greater depth at our 2020 Industry Overview at the WVC.  At the recent VMX conference, even the attendees that were mostly from the companion animal side of the audience enjoyed the presentation that Dr. Cary Christensen delivered on African Swine Fever, also in the news above.  The potential impact and consequences of ASF are enormous and long lasting – big news.

One other news item this week deserves attention – the Super Bowl commercial from WeatherTech that focuses on the care provided by the University of Wisconsin’s veterinary oncologists for the company founder’s Golden Retriever.  It will air in the second quarter, so look out for it.  I’m sure the ad will be talked about on social media and I hope draws attention to treating pets diagnosed with cancer.

Finally, I’d like to draw your attention to a new feature of our newsletter.  Just below this Viewpoint, you’ll see a question that we’d like you to answer.  We’ve had a long history at Brakke Consulting of conducting market research, but this is a way for us to get rapid feedback on timely issues or events.  And, we’ll give you the answers the following week, so you can learn (or laugh) along with us.

To get this started, the question we’ll ask combines the Super Bowl and our industry.  The winner will receive a complimentary admission to the 2020 Industry Overview at the WVC.  If there are multiple winners, we’ll put their names in a hat and draw one out.  We’ll get more serious with the next question, but for now let’s have fun.  And let’s hope it’s a good game on Sunday!

Bob Jones

**********************************
YOUR VIEW

We want to hear from you – share your opinions with us in this one-question poll by clicking below!

How many Super Bowl commercials will feature animals?


Trouble viewing this newsletter?  You can view it online at www.BrakkeConsulting.com

en_USEnglish (United States)